Modus Therapeutics Holding AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was SEK 20.69 million compared to SEK 6.02 million a year ago. Basic loss per share from continuing operations was SEK 1.67 compared to SEK 1.02 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 SEK | +47.52% | +63.14% | +19.88% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.88% | 7.1M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- MODTX Stock
- News Modus Therapeutics Holding AB
- Modus Therapeutics Holding AB Reports Earnings Results for the Full Year Ended December 31, 2021